Table 1.
Contributing Cohorts
| Cohort | Country | Mean age (s.d.) at interview | N Phenotyped | N Cases (ANX=2) | N Controls (ANX=0) | N Analyzed (FS/CC) |
|---|---|---|---|---|---|---|
| MGS Controls (43) | USA | 50.0 (16.4) | 2659 | 757 | 1059 | 2009/1336 |
| PsyCoLaus (44) | Switzerland | 50.9 (8.8) | 3575 | 1044 | 1351 | 2887/1955 |
| RS (45) | Netherlands | 66.5 (10.8) | 9686 | 1112 | 5459 | 7832/5379 |
| SHIP (46) | Germany | 55.4 (13.9) | 2279 | 581 | 890 | 2026/1379 |
| QIMR (47) | Australia | 41.3 (11.5) | 6147 | 1611 | 2544 | 2277/2156 |
| TRAILS (48) | Netherlands | 18.7 (0.7) | 1584 | 390 | 472 | 1155/614 |
| NESDA (49) / NTR (50;51) | Netherlands | 45.6 (14.2) /44.6 (12.7) | 4491 | 1521 | 2970 | NA/4491 |
| Total | 31 060 | 7016 | 14 745 | 18 186/17 310 |
Abbreviations: MGS, Molecular Genetics of Schizophrenia; RS, Rotterdam Study; SHIP, Study of Health in Pomerania; NESDA/NTR, The Netherlands Study of Depression and Anxiety / Netherlands Twin Registry; QIMR, Queensland Institute of Medical Research; TRAILS, Tracking Adolescents' Individual Lives Survey; FS, Factor Score; CC, Case-Control.